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ABSTRACT

Somatostatin (somatotropin release inhibitory factor; SRIF) is a peptide-signaling

molecule that activates a family of heterotrimeric guanine nucleotide binding protein (G

protein) coupled receptors (sst.-sst-).

SRIF receptors control essential intracellular

signaling events and, by reducing cyclic nucleotide levels, ion concentrations and protein

phosphorylation, ultimately controlling cell proliferation and secretion.

In the current

study, we investigated the intracellular phosphatase activity present in the AtT-20 cell, as

well as whether these enzymes were under direct SRIF receptor control.

AtT-20 cells

retain many of the properties of anterior pituitary corticotrophs, yet are an established cell

line that expresses at least

two SRIF receptor subtypes (sst, and sst.).

Both SRIF receptor

subtypes potently suppress hormonally induced adrenocorticotropic hormone (ACTH)

secretion from AtT-20 cells.

Since intracellular protein kinase activation plays a crucial

role in ACTH release from AtT-20 cells, identifying the corresponding protein

phosphatases will provide valuable information on corticotroph function.

The novel

fluorescent phosphatase substrate, 6,8-difluoro-4-methylumbelliferyl phosphate (DiF

MUP) was employed to identify soluble or membrane-associated phosphatase activities.

Treatment with a selective tyrosine phosphatase inhibitor (sodium vanadate; Na3 V04)

attenuated DiF-MUP phosphatase activity by 75%, suggesting that the dominant activity

detected in AtT-20 cells is a tyrosine phosphatase.

Na3V04 inhibition was potent as

concentration response studies demonstrated an inhibitory concentration for 50% activity

(ICso) of 90 nM.

A serine/threonine phosphatase inhibitor failed todecrease phosphatase

activity, indicating that the dominant phosphatase activity present is due to protein
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tyrosine phosphatases.

Immunoprecipitation studies, in conjunction with sodium dodecyl

sulfate polyacrylamide electrophoresis (SDS-P AGE) and immunoblotting identified two

intracellular phosphotyrosine phosphatases: Src homology phosphatase- I (SHP-1) and

Src homology phosphotyrosine phosphatase-2 (SHP-2).

Immunoblotting with phospho

specific antisera confirmed the presence of SHP-1 and SHP-2, while also demonstrating

that neither enzyme appears to be under SRIF control in AtT-20 cells.

Together, these

results show that AtT-20 murine corticotrophs contain sodium vanadate sensitive, soluble

tyrosine phosphatase activity that is independent of SRIF control.
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INTRODUCTION

Protein phosphatases are ubiquitous enzymes responsible for the

dephosphorylation of intracellular proteins.

These enzymes antagonize the effects of

protein kinases, which phosphorylate proteins predominately on serine, threonine and

tyrosine residues.

Three major categories of protein phosphatases have been identified

based on their preference for dephosphorylating the amino acid residues tyrosine,

serine/threonine, or both tyrosine and threonine.

Protein tyrosine phosphatases (PTPs) are categorized into groups that either

contain or lack a transmembrane domain, and are further subdivided into 1 7 groups

(Andersen et al, 2 0 0 1 ) .

PTPs, such as SHP-2 (SH2 containing protein tyrosine

phosphatase 2), contain a src homology 2 (SH2) domain composed of approximately 1 0 0

amino acids, including a tyrosine residue that undergoes phosphorylation, followed by

Glu-Glu-Ile, leading to specificity in signaling control.

PTPs regulate phosphorylated

tyrosine residues, thereby controlling cell growth and differentiation (reviewed in Tonks

and Neel, 1996).

A second type of PTP, S H P - 1 , is responsible for dephosphorylating

signaling molecules such as p27 (Kip 1 ), leading to cell cycle arrest (Pages et al, 1 9 9 9 ) .

Serine/threonine phosphatases regulate diverse cellular mechanisms including glycogen

metabolism, DNA replication, and exocytosis (Sim et al, 2003).

Threonine/tyrosine

phosphatases, known as dual specificity MAPK phosphatases (DS-MKPs) regulate the

mitogen-activated protein kinases (MAPKs), which are critical protein kinases that

regulate diverse physiological events, such as long-term potentiation, and inflammation

(Wera and Hemmings, 1 9 9 5 ; Farooq and Zhou, 2004).

Dual-specificity phosphatases
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(DSPs) aid in controlling the cell cycle by interacting with both MAPKs and stress

activated kinases (Keyse, 1 9 9 9 ) .

Somatostatin (somatotropin release inhibitory factor; SRIF) was originally

identified in the central nervous system as a hypothalamic inhibitor of growth hormone

release (Brazeau et al, 1 9 7 3 ) .

SRIF exists in two distinct forms, S RI F - 1 4 and SRIF-28,

both originating from the SRIF-prepropeptide.

SRIF is distributed throughout the entire

human body, with SRIF-28 predominately localized in the gastrointestinal tract and

S RI F - 1 4 localized to the nervous system (Reisine, 1995).

SRIF peptides regulate a

spectrum of endocrine effects, including thyroid-stimulating hormone (Singh et al, 2000),

modulating gastric acid secretion (Larsson et al, 1979), and inhibiting pancreatic insulin

and glucagon secretion (Strowski et al, 2000).

SRIF carries out its actions by interacting with a group of five highly homologous

SRIF receptors subtypes (sst, - sste), including the sst, receptor splice-variants (sst2A and

sst29).

This receptor family exists in an overlapping expression pattern in many tissue

types throughout the body (Reisine, 1 9 9 5 ; Vanetti et al, 1992).

The SRIF membrane

receptors are seven transmembrane spanning proteins that couple to intracellular

heterotrimeric guanine nucleotide-regulated proteins (G proteins) (Reisine, 1 9 9 5 ) .

Through G protein activation and appropriate effector stimulation, SRIF receptors

regulate cyclic nucleotide levels, membrane ion conductances, and cellular protein

phosphorylation levels (Florio and Schettini, 1996).

AtT-20 cells are a transformed mouse corticotroph cell line which constitutively

express a number of neuronal features, including cytoplasmic processes that resemble
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neuronal growth cones, neurofilament polypeptides, as well as neuron-specific

phosphoprotein synapsin 1 (Tooze et al, 1 9 8 9 ) .

In addition, and of importance in the

current study, the AtT-20 cells endogenously co-express the sst2A, zs, and sst-, but not s s t . ,

3, 4

SRIF receptor subtypes (Strowski et al, 2002; Cervia et al, 2003).

AtT-20 cells retain

the important property of primary corticotrophs, such as the hormonally regulated

secretion of adrenocorticotropic hormone (ACTH) (Gumbiner and Kelly, 1 9 8 1 ; reviewed

in Antoni, 2000).

Both corticotropin-releasing factor (CRF) and leukemia inhibitory

factor (LIF) serve as potent ACTH secretagogues in corticotrophs and AtT-20 cells,

making the AtT-20 cell an attractive model for studying ACTH stimulus-secretion

coupling.

(Vale et al,

1 9 8 3 ; Auernhammer, 1998).

SRIF treatment inhibits ACTH

secretion by reducing intracellular 3 ', 5 ' cyclic adenosine monophosphate ( cAMP) levels

and suppressing calcium ion influx (Heisler et al, 1 9 8 2 ; Ri c h ar d s o n ,1 9 8 3 ) .

Mitogen-activated protein kinases (MAPKs) and signal transducers and activators

of transcription (ST ATs) have also been implicated in ACTH secretion by AtT-20 cells.

Phosphotyrosine phosphatases may dephosphorylate the activated kinases, leading to a

halt in ACTH release.

SRIF's ability to inhibit these intracellular signaling pathways

may be due to the recruitment of protein phosphatases, capable of dephosphorylating the

activated kinases.

In murine NIH 3T3 cells, SRIF regulates dephosphorylation of the

tyrosine residue of Raf-1, a mitogen-activated kinase kinase kinase (MAPKKK), by

stimulating protein tyrosine phosphatase activity (Reardon et al, 1996).

SRIF's

inhibitory effects on AtT-20 cellular function, including the reduction of both cAMP and
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phosphorylated MAPK levels, led us to investigate and identify the possible protein

phosphatase activity within this cell line.

In the current study we have characterized the endogenous protein phosphatase

activity of the AtT-20 murine corticotroph.

Using a fluorescent enzymatic (6,8-difluoro-

4-methylumberiferyll phosphate; DiF-MUP) assay in conjunction with enzymatic

phosphatase inhibitors, immunoprecipitation and immunoblotting we have established the

presence of soluble phosphotyrosine phosphatase activity.

Our results suggest the

presence of a soluble tyrosine phosphatase activity that is independent of SRIF

regulation.
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MATERIALS AND METHODS

Cell culture

The AtT-20 cell line used in this study was a gift from Dr. Terry Reisine (Los

Angeles, CA).

NY).

Cell culture dishes and flasks were purchased from Coming (Coming,

Cell culture growth medium and supplements were purchased from Invitrogen

(Carlsbad, CA).

AtT-20 cells were cultured in Dulbecco's modified Eagle's medium,

DMEM, (with GlutaMAXrn, high glucose, l lOmg/L sodium pyruvate and pyridoxine

1

HCL, Invitrogen, Carlsbad, CA) containing 1 0 0 U ml"

streptomycin, and 1 0 % (v/v) fetal calf serum.

of penicillin, lOOµg ml"

Cultures were maintained in 5% C02 at

2

37°C.

Cell monolayers were grown in T-75cm

flasks and passaged when 75%

2

confluence was reached.

1 : 1 0 dilution.

Cell suspensions were transferred to a new T- 75cm

flask at a

Cells were given 48 hours to recover prior to experimentation.

Tyrosine phosphatase assay

AtT-20 cultures were incubated in the presence or absence of lOOnM SRIF-14

(Peninsula Labs, Belmont, CA) for 30 min.

Cell cultures were washed in PBS and then

lysed in a 50mM HEPES buffer containing 0 . 5 % Triton X - 1 0 0 , 1 0 % glycerol

(GibcoBRL), 2.5µM pepstatin A, 1 2 . 5 µ M leupeptin, 1 2 . 5 µ M aprotinin, 1 2 . 5 µ M

bacitracin and 200nM polymethylsulfonyl fluoride.

Lysates were then centrifuged at

1 3 , 5 0 0 x g for 1 5 min at 6°C and the supernatant retained.

Protein phosphatase assays were performed in a clear bottom 96 well plate

(Coming, Coming, NY).

AtT-20 cell lysate was incubated with varying concentrations

of the fluorescent phosphatase substrate, 6,8-difluoro-4-methylumbelliferyll phosphate
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(DiF-MUP; Gee et al, 1 9 9 9 ; Molecular Probes, Eugene, OR) up to 30 min at 3 7 ° C with

intermittent mixing in a CytoFluor Series 4000 fluorescent plate reader (Applied

Biosystems, CA), with 360nm excitation and 460nm emission filters.

Parallel assays

were conducted in the presence of lOµM Na3V04, an inhibitor of tyrosine phosphatase

activity and a commercial 1 0 mM serine/threonine phosphatase inhibitor cocktail (Sigma,

MO).

The resulting data were analyzed with GraphPad Prism 4.0.

Immunoprecipitation

2

AtT-20 cells were cultured in T-75cm

1 5 minutes with lOOnM SRIF-14.

flasks with DMEM and then incubated for

Cells were washed with 5 mL PBS (with MgCl and

CaCl, Invitrogen, Carlsbad, CA) and lysed with 500 µL of 50mM HEPES buffer.

Supernatants were obtained and incubated overnight with phospho-SHP-1 or SHP-2

antibody (Cell Signaling, MA).

Protein G agarose beads ( 4 5 0 mg/ml., Sigma, St. Louis,

MO) were added and pellets were obtained and washed with 50 µL of 50mM HEPES

buffer and resuspended in 1 X NuP AGE LDS sample buffer.

Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western

blotting

AtT-20 cells were cultured in 12-well plates with medium (DMEM) for 48 h an d

then incubated in the presence or absence of 1 OOnM SRIF-14 for 20 min at 3 re.

cells were then lysed using I X NuPAGE LDS sample buffer.

AtT-20

Cell lysates were sonicated

and heated to 70°C for 1 0 min, resolved on NuPAGE 10% Bis-Tris gels (Invitrogen Life

Technologies, CA) electroblotted onto polyvinyldifluoride (PVJ?F) membranes and

treated for 45 min in a blocking buffer containing 5% (w/v) of Carnation non-fat
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dehydrated milk.

Phospho-SHP-1 and SHP-2 were then immunodetected with a 1 : 1000

dilution of anti phospho-SHP-1 and anti-SHP-2 antibodies, respectively.

The PVDF

membrane associated immunoreactivity were then washed and incubated for 1 hour in a

1 :2000 dilution of a horseradish peroxidase-conjugated anti-rabbit secondary antibody

and detected using ECL chemiluminescence (Amersham, NJ).

The resulting

autoradiograph was scanned and integrated pixel density was obtained using NIH Scion

Imaging software.
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RESULTS

Tyrosine Phosphatase Activity in AtT-20 cell lysate

To identify a possible role of SRIF-14 in controlling AtT-20 cellular phosphatase

activity, experiments using increasing concentrations of the fluorescent substrate DiF-

MUP were performed with AtT-20 cell lysates prepared from untreated and treated ( 1 0 0

nM SRIF-14) cultured cells.

DiF-MUP hydrolysis provides a fluorescent measure of

protein phosphatase activity (Gee et al, 1999).

Cleavage of the phosphate group results

in the product 6,8-difluoro-4-methylumbelliferone, a fluorescent molecule capable of

emitting high levels of fluorescence.

O

F

II

HO-P-O
I

OH
F

Figure 1.

MUP).

Chemical structure of 6,8-difluoro-4-methylumbelliferryl phosphate (DiF

Gee et al, 1999; Molecular Probes, Eugene, OR.

A concentration-response relationship for DiF-MUP was established by

incubating increasing concentrations ofDiF-MUP with a soluble fraction from the AtT-

20 cell lysate (Figure 2).

Non-linear regression analysis of the fluorescence results

revealed an approximate effective concentration for 50% activity (EC50) of

approximately 50 µM.

However, as shown in Figure 2, it should be noted that the lysate

enzyme saturation could ·not be achieved, even at the highest D IF-MUP concentrations

used in this study.

In addition, the concentration-response curve indicates that no
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significant difference exists between SRIF-14 treated and non-treated samples (Figure 2).

Experiments performed with AtT-20 cell membranes prepared from cultured cells

demonstrated similar results, indicating that SRIF-14 had no significant effect on

membrane protein phosphatase activity (data not shown).

Tyrosine Phosphatase Activity in AtT-20 Cell Lysate
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Figure 2.

Tyrosine phosphatase activity in AtT-20 cell lysate.

Cell monolayers were

incubated in the presence or absence of 100 nM SRIF-14 for 1 5 min at 3 7°C.

A soluble

cell lysate was prepared by lysis of the AtT-20 cell monolayers, and fluorescent activity
was assessed in a 96-well using a Cytofluor 4000 fluorescent plate reader (Applied
Biosystems).

Assays were conducted in triplicate and the data m e an ± SEM of twelve

separate experiments are shown.

AtT-20 lysate tyrosine phosphatase inhibition by sodium vanadate (Na3VOJ

DiF-MUP provides a convenient and robust fluorescent measure of protein

phosphatase activity, which when combined with an appropriate enzyme inhibitor, can

help characterize and define the type of phosphatase activity being studied (Gee et al,

1999).

For example, phosphotyrosine phosphatases are exquisitely sensitive to the potent
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tyrosine phosphatase inhibitor sodium vanadate, Na3 V04 (Swarup et al, 1982).

V anadate-mediated enzyme inhibition serves as a readily available marker for

establishing the amount of tyrosine phosphatase activity present in a heterogeneous cell

lysate.

To establish the level of tyrosine phosphatase activity in the AtT-20 cell lysates,

approximately 50 µg of AtT-20 cell lysate was incubated for 1 5 min with 50 µM DiF-

MUP in the presence or absence of 1 0 µM Na3 V04.

DiF-MUP activity was reduced in

AtT-20 cell lysate samples approximately 75% by Na3V04 (Figure 3 ; * p < 0.05 vehicle

AtT-20 Lysate Tyrosine Phosphatase Inhibition ( 1 5 min incubation)
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50µM D i F M U P & 10µM Na3V04

Sodium vanadate attenuates protein phosphatases activity in AtT-20 cell

AtT-20 cell monolayers were prepared in cell lysis buffer and lysates were

incubated 1 5 minutes with 50 µM DiF-MUP in the presence or absence of 1 0 µM
Na3 V04.

Fluorescence was measured using a Cytofluor 4000 plate reader and data were

analyzed in GraphPad Prism 4.0.

One way ANOVA followed by Dunn's non-parametric

post hoc t e s t , * p< 0.05 compared vehicle to Na3V04 treated AtT-20 cells.

To determine the potency ofNa3V04 on tyrosine phosphatase activity, increasing

concentrations of sodium vanadate were added to cell lysates.

The DiF-MUP activity
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found in the cell lysate exhibits a potent sensitivity to Na3 V04, as non-linear regression

analysis of the DiF-MUP inhibition revealed a 50% inhibitory concentration (IC50) of

approximately 90 nM (Figure 4).

Na V0
3

4

Inhibition of Tyrosine Phosphatase Activity

125

(l)

0

c
(l)

1 00

•

0

"'
�
0

:,

75

u.

-

I

c

(l)

•

0

....

(l)

50

c..

25
10-10

1 0 .a

1 0 -6

10

4

[Na3V04, M]

Figure 4.

Sodium vanadate inhibition of DiF-MUP activity in AtT-20 cell lysate.

AtT-20

cell lysates were prepared in the cell lysis buffer and incubated 1 5 minutes with 50µM
9

DiF-MUP and Na3 V04 at concentrations ranging from 10· M to 10

4

M.

The IC50 value in

control cell lysates was 90nM.

AtT-20 cell lysate phosphatase inhibition with serine/threonine cocktail inhibitor

To determine if DiF-MUP hydrolysis is also sensitive to serine/threonine

phosphatase activity, AtT-20 cell lysates were co-incubated with 50 µM DiF-MUP and

1 0 mM serine/threonine phosphatase cocktail inhibitor for 1 5 minutes.

Statistical

analysis of the inhibition data (using Dunn's non-parametric post-hoc test) shows no

significant difference between the cocktail inhibitor treated and non-treated samples,

indicating that serine/threonine phosphatases do not play a significant role in DiF-MUP

hydrolysis under these experimental conditions (Figure 5).
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AtT-20 lysate Phosphatase Assay with Cocktail lnibitor Treatment
( 1 5 min incubation)
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Phosphatase inhibitor cocktail effect on DiF-MUP activity in AtT-20 cell

AtT-20 cell lysates were prepared in the cell lysis buffer and incubated 1 5

minutes with 50µM DiF-MUP and lOmM of the phosphatase inhibitor cocktail.
Fluorescence was measured using a Cytofluor 4000 plate reader and data were analyzed
in GraphPad Prism 4.0.

One-way ANOVA, followed by Dunn's non-parametric post hoc

test, shows no significant difference.

Identification of SHP-2 and Phospho-SHPl in AtT-20 cells

The tyrosine phosphatase SHP-2 has been implicated in SRIF actions in several

cellular models.

For example in S49 cells, the endogenously expressed sst2 receptor

couples an increase in protein tyrosine phosphatase activity to a suppression of MAP

kinase activity (Dent et al, 1997).

SRIF-14 treated and non-treated AtT-20 cell

monolayers were lysed with IX SDS and proteins were separated using gel

electrophoresis.

SHP-2 phosphatase (72 kDa) was detected using an anti-SHP-2

polyclonal antibody.

A paired student T-test was performed demonstrating that the

SRIF-14 treated sample is not significantly different from the control sample.
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Presence of SHP-2 in AtT-20 cells
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Detection of SHP-2 in the AtT-20 cell.

Parallel cultures of AtT-20 cells were

incubated in the presence or absence of 1 0 0 nM SRIF-14 for 20 minutes.

Cell lysates

were separated by SDS-PAGE, electroblotted, and incubated with anti-SHP-2 antibody.
Autoradiographs were quantified using NIH Scion image.
+SEM of three separate experiments.

The results represent the mean

The paired student T-test shows no significant

difference between the vehicle and SRIF-14 treated samples.

The inset shows a

representative autoradiograph.

The SHP-1 phosphatase plays a role in regulating intracellular signaling events

leading to cell cycle arrest and cell growth inhibition (Ferjoux et al, 2003).

A polyclonal

anti-Phospho-SHPl antibody identified the tyrosine phosphatase ( 1 4 0 kDa) in SDS-

PAGE resolved and electroblotted AtT-20 cell lysates.

SRIF-14 did not appear to control

SHP-1 phosphorylation as no statistically significant difference was observed on the

percent integrated density values obtained from the control and SRIF-14 treated samples.

(p > 0.05;

paired Student t-test)
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Presence of Phospho-SHP1 in AtT-20 cells
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Detection of Phospho-SHPl in AtT-20 cells.

AtT-20 cell lysates were

separated by SDS-PAGE, electroblotted and incubated with anti-Phosph-SHPl primary
antibody.

Images were quantified using NIH Scion Image.

mean +SEM of three separate experiments.

The results represent the

The paired student T-test shows no

significant difference between the vehicle and SRIF-14 treated samples.

The inset shows

a representative autoradiograph.
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DISCUSSION

SRIF regulates multiple intracellular signaling pathways such as intracellular ion

concentrations, cyclic nucleotide levels and protein phosphorylation (Blake et al, 2004;

Olias et al, 2004).

Protein phosphorylation controlled by SRIF includes the activation of

phosphoprotein phosphatases (Olias et al, 2004) that are responsible for regulating crucial

cellular events, including cell growth and proliferation, differentiation, and cell cycle

progression.

SRIF receptor subtypes are well documented in the AtT-20 cell, controlling cyclic

nucleotide metabolism (Strowski et al, 2002; Cervia et al, 2003) and hormonal secretion

(Strowski et al, 2002).

In the AtT-20 cell model, SRIF inhibits ACTH release via both

cAMP independent and dependent mechanisms, suggesting that multiple intracellular

events may be under SRIF control (Litvin et al, 1 9 8 6 , Reisine et al, 1 9 8 8 ; Mcferran and

Guild, 1996).

However, whether SRIF events outside of intracellular ion concentrations

or cyclic nucleotide metabolism are affected remains unknown.

In the current study, we

sought to establish and identify the protein phosphatase family of enzymes in the AtT-20

cell, which may serve to inactivate the protein kinases responsible for ACTH secretion.

Within the AtT-20 cell, we have identified at least two cytosolic protein tyrosine

phosphatases, SHP-1 and SHP-2.

We used the fluorescent substrate difluoro-4-

methylumberiferyll phosphate (DiF-MUP) in combination with sodium vanadate to

measure the relative fluorescence of PTPs upon SRIF-treatment, as a means of indirectly

determining phosphatase activity.

Our results demonstrate that basal phosphatase activity
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was not affected by SRIF incubation, suggesting that within AtT-20 cells, PTPs,

including SHP-1 and SHP-2, act independently of SRIF activation.

Both SHP-1 and SHP-2 have been identified in previous studies, but this

experiment provides the first indication of the presence of these protein tyrosine

phosphatases within a corticotroph cell line, such as the AtT-20 cell.

SHP-1 plays a

largely inhibitory role within a cell, negatively regulating both cytokine and growth

receptors, as well as intracellular signaling molecules such as Janus activating kinase 2

(Jak2) (Tonks and Neel, 2 0 0 1 ; Wu et al, 2000).

In the AtT-20 cell, SHP-1 function may

dephosphorylate both growth and cytokine receptors, the CRF- and LIF-receptors,

respectively.

The negative regulation of both G protein coupled receptors and an

interleukin-6 cytokine receptor would prove important in the overall control of ACTH

secretion.

SHP-2 function in a cell demonstrates both negative and positive regulatory roles.

SHP-2 activity involves inactivation and dephosphorylation of both JAK and STAT in rat

brain microglial cells, but it functions as a positive regulator of receptor tyrosine kinase

signaling (Kim et al, 2003; Keyse, 2000).

Within the AtT-20 cell, SHP-2 may co

regulate ACTH secretion with S H P - 1 via a cytokine-induced pathway leading to the

activation of JAK-STAT signaling proteins.

In rat pancreatic cancer cells, both SHP-1

and SHP-2 have been found to work in conjunction with one another by coupling to ssh

(Ferjoux et al, 2003), indicating a potential mechanism for SRIF control of these PTPs.

Our results indicate that within the AtT-20 cell, both SHP-1 and SHP-2 are independent
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of SRIF function, suggesting that neither PTP is docked to the sst, receptor under basal

conditions.

AtT-20 cells endogenously express the SRIF receptor subtypes sst2 and sst 5;

however, sst, has been reported to be the dominant receptor subtype in the rodent

pituitary corticotroph (Patel et al, 1 9 9 6 ) .

Studies have shown that SHP-1 is constitutively

associated with sst-, rather than sst-, and displays antiproliferative effects in CHO

(Chinese hamster ovarian) cells when the stimulated ssh receptor activates the tyrosine

phosphatase (Lopez et al, 1997).

In contrast, CHO cells transfected with sst, do not

recruit either protein tyrosine phosphates or serine/threonine phosphatase (Buscail et al,

1995).

Provided with this information, we can speculate that the AtT-20 cell responds to

SRIF-14 via sst, rather than sst, to regulate the activity of PTPs.

The expression profile

of ssts2&5 in the AtT-20 may explain the inability of S RI F - 1 4 to significantly increase

PTP levels.

A novel approach to clarify the SRIF receptor pharmacology may involve

profiling ssh selective agonist-induced PTP expression.

Delineating SRIF' s intracellular

effects via different receptors could serve to answer the question of why multiple receptor

subtypes are co-expressed in individual cells and tissues, a question that may have

significant therapeutic implications for hormone secretion from SRIF sensitive tissues

(Blake et al, 2004; van der Hoek et al, 2005).

While SRIF has been shown to have no direct effect on basal tyrosine

phosphatase activity in AtT-20 cells, SRIF's effects on stimulated AtT-20 cells has not

been examined.

Clearly, future experiment measuring SRIF's actions on tyrosine

phosphatase activity in LIP-stimulated AtT-20 cells may demonstrate an increase in
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activity.

Leukemia inhibitory factor (LIF), has been shown to increase ACTH secretion

in AtT-20 cells (Auernhammer et al, 1996) through the JAK-STAT intracellular signaling

pathway.

Studies have shown that endogenously expressed LIF receptors stimulate

Janus-activated kinases (JAK), a family of tyrosine kinases located within the AtT-20 cell

membrane. (Stahl et al, 1 9 9 4 ) .

Following activation, signal transduction and activation

of transcription (ST AT) proteins are phosphorylated on tyrosine residues and translocate

to the nucleus to promote the expression of proopiomelanocortin (POMC), the precursor

to ACTH.

SRIF may recruit protein tyrosine phosphatases capable of dephosphorylating

STA T3 on tyrosine residues, preventing nuclear localization and subsequent POMC gene

expression.

Recruitment of PTPs, such as SHP-1 and SHP-2, could occur by association

with ssti, based on the ability these phosphatases to interact with the SRIF receptor

subtype.

The importance of delineating the regulatory mechanism of ACTH secretion from

the murine corticotroph may provide a model relevant in understanding the aberrant

secretory responses in Cushing's syndrome.

Cushing's syndrome is a hormonal disorder

caused by the hyperstimulation of the adrenal gland by ACTH, allowing dangerous levels

of cortisol to be released.

This can be caused by pituitary adenomas and impose

detrimental effects on a patient, including high blood pressure, high blood glucose levels

and obesity.

Currently, research is being conducted on the SRIF pharmacological

analogue, SOM230, and its ability to inhibit ACTH secretion from both human and

mouse corticotroph adenomas (Hofland et al, 2005).

Uncovering a potential role of

protein tyrosine phosphatases in ACTH secretion could assist in understanding the
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mechanism of SOM230 inhibition, solidifying its role as a potential therapeutic agent for

Cushing's syndrome.
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CONCLUSIONS

In summary, the activation of protein kinases within the AtT-20 cell regulates the

cellular processes involved in ACTH secretion.

SRlF has been shown to inhibit the

secretion of ACTH in AtT-20 cells by regulating cyclic nucleotide levels, ion

conductance, and protein phosphorylation.

While the protein kinases involved in AtT-20

cellular mechanisms have been well characterized, protein phosphatases responsible for

antagonizing protein kinase effects have yet to be determined.

Our results demonstrate that AtT-20 cells contain a soluble protein phosphatase

activity capable of hydrolyzing the fluorescent substrate DiF-MUP.

This protein

phosphatase activity is independent of SRIF control, but is exquisitely sensitive to

sodium vanadate, a potent tyrosine phosphatase inhibitor.

The sensitivity of the

enzymatic activity to sodium vanadate indicates that protein tyrosine phosphatases are

present within the AtT-20 cell.

Further inspection of this activity led to the identification

of the protein tyrosine phosphatases SHP-2 and SHP-1 within the murine corticotroph,

however neither phosphatase was under the control of SRlF.

AtT-20 cells endogenously co-express three SRJF receptors; sst2A, sst2B, and sst«

Future studies, with receptor-selective agonists, should be used to delineate each

receptor's influence on SRIF's effects on tyrosine phosphatase activity in AtT-20 cells.

Further investigation of tyrosine phosphatase recruitment in AtT-20 cells stimulated by

LIF should be performed in order to develop a possible regulatory mechanism of ACTH

secretion.

This information could lead to a better understanding of how ACTH secretion
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controlled in AtT-20 cells and provide possible therapeutic implications in diseases such

as Cushing's syndrome.
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